Clinical Trial Update: A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Conditional Labeling

View source ↗

Summary

A post-market study evaluating the safety of the Infinity DBS System with MR conditional labeling has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystonia
• Essential Tremor
• Parkinson Disease

Drugs mentioned

• Infinity DBS System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Movement Disorders, Parkinson Disease | Status: COMPLETED | Results posted: 2024-11-20